CA
ONC

Cliff Asness’s BeOne Medicines Ltd ONC Stock Holding History

Cliff Asness’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,486
Closed -$1.21M – 2269
2022
Q4 		$1.21M Sell
5,486
-72,021
-93% -$13.2M ﹤0.01% 1482
2022
Q3 		$10.4M Sell
77,507
-104
-0.1% -$17.9K 0.03% 631
2022
Q2 		$12.6M Sell
77,611
-341
-0.4% -$53.3K 0.03% 616
2022
Q1 		$14.7M Sell
77,952
-729
-0.9% -$155K 0.03% 623
2021
Q4 		$21.3M Sell
78,681
-2,235
-3% -$755K 0.04% 471
2021
Q3 		$29.4M Sell
80,916
-513
-0.6% -$168K 0.05% 377
2021
Q2 		$27.9M Buy
81,429
+22
+0% +$7.29K 0.05% 410
2021
Q1 		$28.3M Buy
81,407
+18,914
+30% +$6.26M 0.05% 407
2020
Q4 		$16.1M Buy
+62,493
New +$17.2M 0.03% 499

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cliff Asness's ONC Position: Q1 2023 in Review

Cliff Asness sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 5,486 shares — an estimated $1.21M sold.

Cliff Asness first reported a position in ONC in Q4 2020 and held it in 9 quarters. The position peaked at $29.4M in Q3 2021. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • Cliff Asness reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • Cliff Asness sold 5,486 BeOne Medicines Ltd shares in Q1 2023, an estimated $1.21M.
  • Cliff Asness first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 9 quarters.
  • Cliff Asness's BeOne Medicines Ltd position peaked at $29.4M in Q3 2021.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on AQR Capital Management's 13F filing for Q1 2023, filed 15 May 2023.